| Disease ID | Disease name | Source of annotation with IKBKG | OMIM link | Number of associated genes | genes |
|---|---|---|---|---|---|
| 300301 | ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNODEFICIENCY, OSTEOPETROSIS, AND LYMPHEDEMA | ClinVar, OMIM | link to OMIM | 1 | IKBKG |
| 308300 | INCONTINENTIA PIGMENTI | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | IKBKG |
| 300636 | IMMUNODEFICIENCY 33 | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | IKBKG |
| 300291 | ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | IKBKG |
| PS610799 | INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED | ClinVar, OMIM, HUMSAVAR | link to OMIM | 3 | IKBKG, TIRAP, IRAK4 |
| 300584 | IMMUNODEFICIENCY WITHOUT ANHIDROTIC ECTODERMAL DYSPLASIA | OMIM, HUMSAVAR | link to OMIM | 1 | IKBKG |
Download the gene annotation in CSV format
| KEGG pathway | KEGG ID | KEGG IC |
|---|---|---|
| Shigellosis | hsa05131 | 6.74 |
| Pancreatic cancer | hsa05212 | 6.56 |
| MAPK signaling pathway | hsa04010 | 4.63 |
| Prostate cancer | hsa05215 | 6.11 |
| Primary immunodeficiency | hsa05340 | 7.52 |
| Osteoclast differentiation | hsa04380 | 5.64 |
| NF-kappa B signaling pathway | hsa04064 | 6.21 |
| Chemokine signaling pathway | hsa04062 | 5.19 |
| Adipocytokine signaling pathway | hsa04920 | 6.6 |
| Chagas disease (American trypanosomiasis) | hsa05142 | 5.99 |
| Herpes simplex infection | hsa05168 | 5.08 |
| Epstein-Barr virus infection | hsa05169 | 4.97 |
| Toxoplasmosis | hsa05145 | 5.71 |
| Apoptosis | hsa04210 | 6.23 |
| HTLV-I infection | hsa05166 | 4.59 |
| Hepatitis C | hsa05160 | 5.68 |
| Hepatitis B | hsa05161 | 5.52 |
| Epithelial cell signaling in Helicobacter pylori infection | hsa05120 | 6.58 |
| Toll-like receptor signaling pathway | hsa04620 | 6.0 |
| NOD-like receptor signaling pathway | hsa04621 | 6.88 |
| Viral carcinogenesis | hsa05203 | 5.08 |
| Pathways in cancer | hsa05200 | 3.98 |
| T cell receptor signaling pathway | hsa04660 | 6.01 |
| B cell receptor signaling pathway | hsa04662 | 6.52 |
| Ras signaling pathway | hsa04014 | 4.9 |
| RIG-I-like receptor signaling pathway | hsa04622 | 6.62 |
| Acute myeloid leukemia | hsa05221 | 6.74 |
| Chronic myeloid leukemia | hsa05220 | 6.48 |
| TNF signaling pathway | hsa04668 | 5.96 |
| Cytosolic DNA-sensing pathway | hsa04623 | 6.79 |
| PI3K-Akt signaling pathway | hsa04151 | 4.21 |
| Small cell lung cancer | hsa05222 | 6.17 |
| REACTOME pathway | REACTOME ID | REACTOME IC |
|---|---|---|
| TRIF-mediated TLR3/TLR4 signaling | R-HSA-937061 | 6.47 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.06 |
| Signaling by Interleukins | R-HSA-449147 | 4.71 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.46 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.51 |
| Immune System | R-HSA-168256 | 2.37 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.56 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.73 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.34 |
| RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways | R-HSA-168928 | 6.7 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.11 |
| Innate Immune System | R-HSA-168249 | 3.17 |
| Adaptive Immune System | R-HSA-1280218 | 3.19 |
| Disease | R-HSA-1643685 | 3.33 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 9.18 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.73 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 10.18 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.47 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.68 |
| Toll-Like Receptors Cascades | R-HSA-168898 | 5.91 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.59 |
| MyD88-independent TLR3/TLR4 cascade | R-HSA-166166 | 6.47 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.28 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.94 |
| TCR signaling | R-HSA-202403 | 6.64 |
| Interleukin-1 signaling | R-HSA-446652 | 7.52 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.4 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 9.4 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.59 |
| Downstream TCR signaling | R-HSA-202424 | 7.01 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.11 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.68 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.85 |
| MAP kinase activation in TLR cascade | R-HSA-450294 | 7.28 |
| TAK1 activates NFkB by phosphorylation and activation of IKKs complex | R-HSA-445989 | 8.08 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.59 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.94 |
| Diseases of Immune System | R-HSA-5260271 | 8.34 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 9.98 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 9.18 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.51 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 11.4 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.72 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.73 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.31 |
| MyD88:Mal cascade initiated on plasma membrane | R-HSA-166058 | 6.56 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.38 |
| Activated TLR4 signalling | R-HSA-166054 | 6.27 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.66 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.62 |
| GO term | GO ID | GO IC |
|---|---|---|
| linear polyubiquitin binding | GO:1990450 | 9.74 |
| ubiquitin-like protein ligase binding | GO:0044389 | 4.15 |
| enzyme binding | GO:0019899 | 2.27 |
| binding | GO:0005488 | 0.18 |
| signal transducer activity | GO:0004871 | 2.28 |
| polyubiquitin binding | GO:0031593 | 5.98 |
| cation binding | GO:0043169 | 1.4 |
| ion binding | GO:0043167 | 1.36 |
| transferase activity | GO:0016740 | 1.95 |
| K63-linked polyubiquitin binding | GO:0070530 | 6.79 |
| metal ion binding | GO:0046872 | 1.41 |
| identical protein binding | GO:0042802 | 2.63 |
| protein homodimerization activity | GO:0042803 | 3.16 |
| kinase activity | GO:0016301 | 2.93 |
| catalytic activity | GO:0003824 | 1.05 |
| protein domain specific binding | GO:0019904 | 3.32 |
| protein dimerization activity | GO:0046983 | 2.72 |
| ubiquitin protein ligase binding | GO:0031625 | 4.17 |
| transferase activity, transferring phosphorus-containing groups | GO:0016772 | 2.77 |
| ubiquitin-like protein binding | GO:0032182 | 4.93 |
| ubiquitin binding | GO:0043130 | 5.09 |
| protein binding | GO:0005515 | 0.46 |
| peroxisome proliferator activated receptor binding | GO:0042975 | 7.03 |
| receptor binding | GO:0005102 | 2.43 |
| protein heterodimerization activity | GO:0046982 | 3.64 |